Pressure BioSciences (OTCQB: PBIO) has announced that it will be presenting at the upcoming Life Sciences Investor Forum (“LSIF”). The leading proprietary investor conference is scheduled for Dec. 17, 2020, and is a live, interactive investor event held quarterly for public … Continue reading →

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative solutions for the worldwide life science and other industries, recently reported its third-quarter financial results and provided a business update, which included initial expectations for 2021 (https://ibn.fm/8PNFi). Among the updates, the … Continue reading →

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative solutions for the worldwide life science and other industries, recently secured its first U.S. patent for its innovative Ultra Shear Technology (“UST”) platform. Utilizing ultra-high pressure and intense shearing forces, the … Continue reading →

Pressure BioSciences (OTCQB: PBIO), a developer of innovative solutions for the worldwide life science and other industries, recently achieved another milestone as it nears initial production of commercial systems expected to revolutionize the nanoemulsification process for a wide variety of … Continue reading →

Pressure BioSciences has been making a name for itself as a leader in the development and sale of proprietary intense-pressure delivery systems to the worldwide life sciences field PBIO is developing a novel high pressure platform called Ultra-Shear Technology (“UST”) … Continue reading →

Pressure BioSciences (OTCQB: PBIO) recently announced its receipt of a pivotal U.S. patent for “Sample Preparation Devices and Methods,” which expands its already significant intellectual property (“IP”) portfolio. This award increases Pressure BioSciences’ IP ownership to include 25 issued patents … Continue reading →